Vimarsana
Biggest News Aggregation in the World

Reporting Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reporting Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reporting Trials Today - Breaking & Trending Today

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules - Vimarsana News

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

Amanda Leach and colleagues compare two pneumococcal conjugate vaccines to examine the impact on hearing loss

Source: plos.org
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial | Chronic Obstructive Pulmonary Disease | JAMA - Vimarsana News

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial | Chronic Obstructive Pulmonary Disease | JAMA

This study examines whether the addition of bisoprolol to treatment of people with chronic obstructive pulmonary disease (COPD) at high risk of

Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial - Vimarsana News

Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial

Objective To determine whether a single low dose of esketamine administered after childbirth reduces postpartum depression in mothers with prenatal depression. Design Randomised, double blind, placebo controlled trial with two parallel arms. Setting Five tertiary care hospitals in China, 19 June 2020 to 3 August 2022. Participants 364 mothers aged ≥18 years who had at least mild prenatal depression as indicated by Edinburgh postnatal depression scale scores of ≥10 (range 0-30, with higher scores indicating worse depression) and who were admitted to hospital for delivery. Interventions Part...

Source: bmj.com
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality - Vimarsana News

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality

This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at

The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial - Vimarsana News

The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial

Lise Christine Gaudernack and team assess the effect of hyoscine butylbromide on the duration of labor in nulliparous women showing early signs of slow labor.

Source: plos.org